Search Results

There are 8162763 results for: content related to: Erratum: Nervous System Post-Transplantation Lymphoproliferative Disorder

  1. You have free access to this content
    Erratum: Activity and Tolerability of Nilotinib: A Retrospective Multicenter Analysis of Chronic Myeloid Leukemia Patients Who Are Imatinib Resistant or Intolerant

    Cancer

    Volume 117, Issue 1, 1 January 2011, Page: 230, Maya Koren-Michowitz, Philipp le Coutre, Justus Duyster, Christof Scheid, Panayiotis Panayiotidis, Witold Prejzner, Jacob M. Rowe, Michaela Schwarz, Neta Goldschmidt and Arnon Nagler

    Version of Record online : 27 AUG 2010, DOI: 10.1002/cncr.25569

    This article corrects:

    Activity and tolerability of nilotinib

    Vol. 116, Issue 19, 4564–4572, Version of Record online: 19 AUG 2010

  2. You have free access to this content
    Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase

    Cancer

    Volume 117, Issue 23, 1 December 2011, Pages: 5261–5270, Alfonso Quintás-Cardama, Jorgé E. Cortes and Hagop M. Kantarjian

    Version of Record online : 19 MAY 2011, DOI: 10.1002/cncr.26196

  3. You have free access to this content
    Complete cytogenetic and molecular responses to interferon-α-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis

    Cancer

    Volume 97, Issue 4, 15 February 2003, Pages: 1033–1041, Hagop M. Kantarjian, Susan O'Brien, Jorge E. Cortes, Jianqin Shan, Francis J. Giles, Mary Beth Rios, Stefan H. Faderl, William G. Wierda, Alessandra Ferrajoli, Srdan Verstovsek, Michael J. Keating, Emil J. Freireich and Moshe Talpaz

    Version of Record online : 3 FEB 2003, DOI: 10.1002/cncr.11223

  4. You have full text access to this OnlineOpen article
    Suboptimal responses in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1181–1191, Elias Jabbour, Giuseppe Saglio, Timothy P. Hughes and Hagop Kantarjian

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26391

  5. You have free access to this content
    Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy

    Cancer

    Volume 116, Issue 11, 1 June 2010, Pages: 2673–2681, Dushyant Verma, Hagop Kantarjian, Jianqin Shan, Susan O'Brien, Zeev Estrov, Guillermo Garcia-Manero, Charles Koller, Gautam Borthakur and Jorge Cortes

    Version of Record online : 29 MAR 2010, DOI: 10.1002/cncr.25015

  6. You have free access to this content
    Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

    Cancer

    Volume 97, Issue 9, 1 May 2003, Pages: 2225–2228, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, Kevin White, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, William Wierda, Steven Kornblau and Jorge Cortes

    Version of Record online : 17 APR 2003, DOI: 10.1002/cncr.11381

  7. You have free access to this content
    Long-term survival estimates for imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

    Cancer

    Volume 101, Issue 11, 1 December 2004, Pages: 2584–2592, Kevin J. Anstrom, Shelby D. Reed, Andrew S. Allen, G. Alastair Glendenning and Kevin A. Schulman

    Version of Record online : 18 OCT 2004, DOI: 10.1002/cncr.20674

  8. You have free access to this content
    Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

    Cancer

    Volume 68, Issue 6, 15 September 1991, Pages: 1201–1207, Hagop M. Kantarjian, Moshe Talpaz, Michael J. Keating, Elihu H. Estey, Susan O'brien, Miloslav Beran, Kenneth B. McCredie, Jordan Gutterman and Emil J Freireich

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19910915)68:6<1201::AID-CNCR2820680604>3.0.CO;2-1

  9. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  10. You have free access to this content
    Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

    Cancer

    Volume 98, Issue 8, 15 October 2003, Pages: 1776–1777, Mark W. Drummond and Tessa L. Holyoake

    Version of Record online : 25 AUG 2003, DOI: 10.1002/cncr.11715

  11. You have free access to this content
    First-line therapy for chronic myeloid leukemia: Past, present, and future

    American Journal of Hematology

    Volume 84, Issue 5, May 2009, Pages: 287–293, Carolina Pavlovsky, Hagop Kantarjian and Jorge E. Cortes

    Version of Record online : 19 FEB 2009, DOI: 10.1002/ajh.21380

  12. You have free access to this content
    Chronic myelogenous leukemia: A review and update of therapeutic strategies

    Cancer

    Volume 98, Issue 3, 1 August 2003, Pages: 437–457, Guillermo Garcia-Manero, Stefan Faderl, Susan O'Brien, Jorge Cortes, Moshe Talpaz and Hagop M. Kantarjian

    Version of Record online : 4 JUN 2003, DOI: 10.1002/cncr.11520

  13. You have free access to this content
    Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: Does body weight matter?

    American Journal of Hematology

    Volume 83, Issue 11, November 2008, Pages: 835–839, Yoshinobu Kanda, Shinichiro Okamoto, Tetsuzo Tauchi, Masahiro Kizaki, Koiti Inokuchi, Mariko Yabe, Kenji Yokoyama, Yoshikazu Ito, Yukihiko Kimura, Masaaki Higashihara, Masami Bessho, Kiyoshi Ando, Shigeru Chiba, Mineo Kurokawa, Kazuo Oshimi, Kazuo Dan, Kazuma Ohyashiki and Yasuo Ikeda

    Version of Record online : 21 AUG 2008, DOI: 10.1002/ajh.21274

  14. You have free access to this content
    Imatinib in Philadelphia chromosome-positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome

    American Journal of Hematology

    Volume 73, Issue 4, August 2003, Pages: 249–255, Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, Michaela Schwarz, Joachim Lupberger, Matthias Holdhoff, Gökben Baskaynak, Harald Gschaidmeier, Uwe Platzbecker, Gerhard Ehninger, Witold Prejzner, Dieter Huhn and Christian A. Schmidt

    Version of Record online : 18 JUL 2003, DOI: 10.1002/ajh.10364

  15. Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia

    Pediatric Blood & Cancer

    Volume 47, Issue 5, 15 October 2006, Pages: 555–559, Frédéric Millot, Joelle Guilhot, Brigitte Nelken, Thierry Leblanc, Guy Leverger, Frédéric Bernard, Virginie Gandemer, Catherine Béhard, Claire Berger, Guy Cornu, Sylvain Duchène and François Guilhot

    Version of Record online : 29 NOV 2005, DOI: 10.1002/pbc.20586

  16. You have free access to this content
    Monitoring molecular response in chronic myeloid leukemia

    Cancer

    Volume 117, Issue 6, 15 March 2011, Pages: 1113–1122, Jorge Cortes, Alfonso Quintás-Cardama and Hagop M. Kantarjian

    Version of Record online : 19 OCT 2010, DOI: 10.1002/cncr.25527

  17. You have free access to this content
    Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase

    Cancer

    Volume 98, Issue 12, 15 December 2003, Pages: 2636–2642, Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Francis J. Giles, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, William Wierda, Michael Keating and Moshe Talpaz

    Version of Record online : 3 NOV 2003, DOI: 10.1002/cncr.11831

  18. You have free access to this content
    Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

    Cancer

    Volume 98, Issue 9, 1 November 2003, Pages: 1905–1911, Jorge Medina, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Francis Giles, Mary Beth Rios, Kimberly Hayes and Jorge Cortes

    Version of Record online : 17 SEP 2003, DOI: 10.1002/cncr.11729

  19. You have free access to this content
    Simultaneous homoharringtonine and interferon-α in the treatment of patients with chronic-phase chronic myelogenous leukemia

    Cancer

    Volume 94, Issue 7, 1 April 2002, Pages: 2024–2032, Susan O'Brien, Moshe Talpaz, Jorge Cortes, Jianqin Shan, Francis J. Giles, Stefan Faderl, Deborah Thomas, Guillermo Garcia-Manero, Susie Mallard, Mary Beth Rios, Charles Koller, Steve Kornblau, Michael Andreeff, Anthony Murgo, Michael Keating and Hagop M. Kantarjian

    Version of Record online : 28 MAR 2002, DOI: 10.1002/cncr.10436

  20. Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment

    Genes, Chromosomes and Cancer

    Volume 21, Issue 2, February 1998, Pages: 90–100, Josef Mühlmann, Josef Thaler, Wolfgang Hilbe, Oliver Bechter, Martin Erdel, Gerd Utermann and Hans-Christoph Duba

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2264(199802)21:2<90::AID-GCC3>3.0.CO;2-2